Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicament for treating acute inflammatory demyelinating polyneuropathies and preparation method of medicament

A polyneuropathy, acute inflammation technology, applied in nervous system diseases, drug combinations, pharmaceutical formulations, etc., can solve problems such as large side effects, and achieve the effect of promoting application

Inactive Publication Date: 2015-01-21
HARBIN JINYU SCI & TECH
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, plasma exchange, intravenous infusion of immunoglobulin, etc., and oral administration of western medicine are generally used to treat this disease. During the treatment process of the above-mentioned methods, the patients suffer great pain, and the side effects are relatively large, and even heart failure and other symptoms may occur, which has certain risks. sex

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] A medicine for acute inflammatory demyelinating polyneuropathy, prepared according to the following parts by weight ratio: 9-14 parts of oryzanol, 6-11 parts of Sangjisheng, 5-10 parts of Qiannianjian, and 6-12 parts of frankincense , 4-11 parts of loofah, 5-10 parts of curculigo, 6-9 parts of overlord flower, 5-8 parts of lost stick, 5-11 parts of golden button head, 6-12 parts of red madder, 5-10 parts of cork , Zhitian pepper 5-10 parts, mountain orange 6-11 parts, Cynomorium 5-12 parts, wolfberry root 5-10 parts, Eucommia 6-11 parts, Magnolia officinalis 5-10 parts, Qianjinzi 4-8 parts, Solidago 5-9 parts. See Example 2 for the preparation method.

[0039] Typical cases:

[0040] Li, female, 36 years old, the patient said that her limbs were sore and weak, and her lower limbs gradually became paralyzed within two weeks. Yellow and greasy fur was diagnosed as acute inflammatory demyelinating polyneuropathy. After giving the capsule of the present invention for on...

Embodiment 2

[0042] Prepared according to the following weight ratios: 9 parts of oryzanol, 11 parts of Sangjisheng, 8 parts of Qiannianjian, 12 parts of frankincense, 4 parts of loofah, 7 parts of curculigo, 7 parts of Bawanghua, 8 parts of lost stick, golden 5 parts of button head, 6 parts of red madder, 10 parts of cortex, 5 parts of chili pepper, 9 parts of mountain orange, 9 parts of Cynomorium, 10 parts of wolfberry root, 11 parts of Eucommia, 5 parts of Magnolia officinalis, 6 parts of Qianjinzi, one stick Yellow flower 7 parts.

[0043] Preparation method: prepared by the following steps,

[0044] (1) Remove impurities from the above-mentioned Chinese medicine raw materials, dry them in the sun, grind them into powder, and mix them evenly; (2) Put the above-mentioned Chinese medicine raw materials in a silver bucket and seal them, store them for 10 days, take them out and wrap them in kraft paper, and then Dry in the shade for 2 days; (3) Stir oryzanol and the traditional Chine...

Embodiment 3

[0048] Prepared according to the following weight ratios: 11 parts of oryzanol, 8 parts of Sangjisheng, 5 parts of Qiannianjian, 6 parts of frankincense, 7 parts of loofah, 5 parts of curculigo, 9 parts of Bawanghua, 5 parts of lost stick, 8 parts of button head, 10 parts of red madder, 7 parts of cortex, 10 parts of chili pepper, 11 parts of mountain orange, 5 parts of Cynomorium, 8 parts of wolfberry root, 6 parts of Eucommia, 7 parts of Magnolia officinalis, 8 parts of Qianjinzi, one stick 5 servings of goldenrod. The preparation method is the same as in Example 2.

[0049] Typical cases:

[0050] Pan, male, 34 years old, the condition is relatively slow. Within three weeks, the limbs gradually flaccid, the waist and knees are sore and weak, and the muscles are thin, accompanied by dizziness and tinnitus, red tongue with less coating, and thready pulse. The diagnosis is acute inflammatory demyelinating Polyneuropathy: Symptoms improved after one course of treatment with c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicament for treating acute inflammatory demyelinating polyneuropathies and a preparation method of the medicament. The medicament is prepared from the following components in parts by weight: 9-14 parts of oryzanol, 6-11 parts of Chinese taxillus twigs, 5-10 parts of obscured homalomena rhizome, 6-12 parts of frankincense, 4-11 parts of towel gourd vegetable sponge, 5-10 parts of common curculigo rhizome, 6-9 parts of pitaya flower, 5-8 parts of claoxylon polot, 5-11 parts of root of water nightshade, 6-12 parts of red madder, 5-10 parts of amur corktree bark, 5-10 parts of conical redpepper fruits, 6-11 parts of mountain oranges, 5-12 parts of songaria cynomorium herb, 5-10 parts of wolfberry root, 6-11 parts of eucommia bark, 5-10 parts of officinal magnolia bark, 4-8 parts of caper euphorbia seeds and 5-9 parts of solidago Canadensis. The medicament provided by the invention has a great effect on treatment of acute inflammatory demyelinating polyneuropathies. The preparation method comprises the processes of grinding, sealing and the like, and the method is simple, applicable, easy to operate and conductive to popularization and application.

Description

Technical field [0001] The present invention involves a drug and preparation method of acute inflammatory desertemic hypotina. Background technique [0002] Acute inflammatory deserticiasis multi -neuropathy, the main lesion is the inflammatory depaidity of neuropathy surrounding the nerve root. Sometimes it also affects spinal, spinal cord and brain, and clinical characteristics to develop rapidly limb symmetry and weakness.Disappearing.Those with severe condition have experienced marrow and respiratory muscle paralysis and life -threatening.This disease occurs mostly in young people and children. Men are slightly more, and there are slightly more in winter and summer.About 2 / 3 patients have a history of upper respiratory or digestive tract infection a few days to weeks before the onset.At present, the treatment of this disease generally uses plasma exchange, immunoglobulin intravenous injection and other methods, and oral oral methods of western medicine. Patients with the abov...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/888A61P25/02A61P29/00
CPCA61K36/888A61K31/575A61K36/185A61K36/24A61K36/28A61K36/324A61K36/33A61K36/42A61K36/46A61K36/47A61K36/575A61K36/74A61K36/756A61K36/81A61K36/815A61K36/88A61K2300/00
Inventor 张守良
Owner HARBIN JINYU SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com